SG49638A1 - Bicyclo[2.2.2] octane derivatives - Google Patents
Bicyclo[2.2.2] octane derivativesInfo
- Publication number
- SG49638A1 SG49638A1 SG1996002191A SG1996002191A SG49638A1 SG 49638 A1 SG49638 A1 SG 49638A1 SG 1996002191 A SG1996002191 A SG 1996002191A SG 1996002191 A SG1996002191 A SG 1996002191A SG 49638 A1 SG49638 A1 SG 49638A1
- Authority
- SG
- Singapore
- Prior art keywords
- carboxy
- halo
- group
- alkyl
- carboxymethyl
- Prior art date
Links
- GPRLTFBKWDERLU-UHFFFAOYSA-N bicyclo[2.2.2]octane Chemical class C1CC2CCC1CC2 GPRLTFBKWDERLU-UHFFFAOYSA-N 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 7
- 125000005843 halogen group Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- -1 carboxy, carboxymethyl Chemical group 0.000 abstract 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 2
- 108010089448 Cholecystokinin B Receptor Proteins 0.000 abstract 1
- 102000004859 Cholecystokinin Receptors Human genes 0.000 abstract 1
- 108090001085 Cholecystokinin Receptors Proteins 0.000 abstract 1
- 102000052874 Gastrin receptors Human genes 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/86—Ring systems containing bridged rings containing four rings
- C07C2603/88—Ethanoanthracenes; Hydrogenated ethanoanthracenes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Indole Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939316722A GB9316722D0 (en) | 1993-08-12 | 1993-08-12 | Bicyclo (2.2.2)octane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG49638A1 true SG49638A1 (en) | 1998-06-15 |
Family
ID=10740353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996002191A SG49638A1 (en) | 1993-08-12 | 1994-08-09 | Bicyclo[2.2.2] octane derivatives |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0719251B1 (de) |
| JP (1) | JPH09501438A (de) |
| AT (1) | ATE174327T1 (de) |
| AU (1) | AU689788B2 (de) |
| CA (1) | CA2167156A1 (de) |
| DE (1) | DE69415165D1 (de) |
| FI (1) | FI960571A0 (de) |
| GB (1) | GB9316722D0 (de) |
| HU (1) | HUT74570A (de) |
| NO (1) | NO960467D0 (de) |
| NZ (1) | NZ269826A (de) |
| PL (1) | PL312959A1 (de) |
| SG (1) | SG49638A1 (de) |
| WO (1) | WO1995005359A1 (de) |
| ZA (1) | ZA946087B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3459497A (en) * | 1996-07-12 | 1998-02-09 | Chugai Seiyaku Kabushiki Kaisha | Cancer cell proliferation inhibitors |
| EP1534273A4 (de) * | 2002-07-18 | 2007-08-22 | Bristol Myers Squibb Co | Modulatoren des glucocorticoid-rezeptors und verfahren |
| US7253283B2 (en) | 2004-01-16 | 2007-08-07 | Bristol-Myers Squibb Company | Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7605264B2 (en) * | 2004-01-16 | 2009-10-20 | Bristol-Myers Squibb Company | Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7625921B2 (en) | 2004-01-16 | 2009-12-01 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7326728B2 (en) | 2004-01-16 | 2008-02-05 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof |
| US7569689B2 (en) * | 2004-01-16 | 2009-08-04 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7273881B2 (en) | 2004-01-16 | 2007-09-25 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7317024B2 (en) | 2005-01-13 | 2008-01-08 | Bristol-Myers Squibb Co. | Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7642273B2 (en) | 2005-01-13 | 2010-01-05 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7361654B2 (en) | 2005-01-13 | 2008-04-22 | Bristol-Myers Squibb Co. | Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7411071B2 (en) | 2005-01-13 | 2008-08-12 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ234264A (en) * | 1989-06-29 | 1993-05-26 | Warner Lambert Co | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions |
| WO1993008175A1 (en) * | 1991-10-24 | 1993-04-29 | Glaxo Group Limited | Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin |
| NZ249202A (en) * | 1992-02-20 | 1996-06-25 | Black James Foundation | Bicyclo[2.2.2.]octane derivatives, preparation and pharmaceutical compositions thereof |
-
1993
- 1993-08-12 GB GB939316722A patent/GB9316722D0/en active Pending
-
1994
- 1994-08-09 NZ NZ269826A patent/NZ269826A/en unknown
- 1994-08-09 JP JP7506801A patent/JPH09501438A/ja active Pending
- 1994-08-09 SG SG1996002191A patent/SG49638A1/en unknown
- 1994-08-09 AU AU73477/94A patent/AU689788B2/en not_active Ceased
- 1994-08-09 EP EP94922317A patent/EP0719251B1/de not_active Expired - Lifetime
- 1994-08-09 AT AT94922317T patent/ATE174327T1/de not_active IP Right Cessation
- 1994-08-09 CA CA002167156A patent/CA2167156A1/en not_active Abandoned
- 1994-08-09 DE DE69415165T patent/DE69415165D1/de not_active Expired - Lifetime
- 1994-08-09 PL PL94312959A patent/PL312959A1/xx unknown
- 1994-08-09 WO PCT/GB1994/001740 patent/WO1995005359A1/en not_active Ceased
- 1994-08-09 HU HU9600069A patent/HUT74570A/hu unknown
- 1994-08-12 ZA ZA946087A patent/ZA946087B/xx unknown
-
1996
- 1996-02-05 NO NO960467A patent/NO960467D0/no unknown
- 1996-02-07 FI FI960571A patent/FI960571A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09501438A (ja) | 1997-02-10 |
| GB9316722D0 (en) | 1993-09-29 |
| NO960467L (no) | 1996-02-05 |
| NZ269826A (en) | 1996-10-28 |
| CA2167156A1 (en) | 1995-02-23 |
| EP0719251A1 (de) | 1996-07-03 |
| ATE174327T1 (de) | 1998-12-15 |
| DE69415165D1 (de) | 1999-01-21 |
| WO1995005359A1 (en) | 1995-02-23 |
| HU9600069D0 (en) | 1996-03-28 |
| NO960467D0 (no) | 1996-02-05 |
| AU689788B2 (en) | 1998-04-09 |
| FI960571A7 (fi) | 1996-02-07 |
| ZA946087B (en) | 1996-02-12 |
| AU7347794A (en) | 1995-03-14 |
| HUT74570A (en) | 1997-01-28 |
| PL312959A1 (en) | 1996-05-27 |
| EP0719251B1 (de) | 1998-12-09 |
| FI960571A0 (fi) | 1996-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG49638A1 (en) | Bicyclo[2.2.2] octane derivatives | |
| HU9402280D0 (en) | Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors | |
| EA199900678A1 (ru) | Производные амида гетероарил-гексановой кислоты, их получение и их применение в качестве селективных ингибиторов связывания mip-1-альфа с его рецептором ccr1 | |
| UA66778C2 (uk) | Похідні індану або дигідроіндолу | |
| CA2254066A1 (en) | Compounds with anti-inflammatory and immunosuppressive activities | |
| NZ337967A (en) | 3,3-Diarylpropylamines and their use in the treatment of urinary incontinence | |
| IL110151A0 (en) | Amide and urea derivatives and pharmaceutical compositions containing the same | |
| TW225513B (de) | ||
| HUT68056A (en) | Substituted indoles and azaindoles as angiotensin ii antagonists, pharmaceutical compositions containing same, process for their production and intermediates | |
| MY113266A (en) | New indol derivatives derivatives with high affinity 5-ht1a receptor. | |
| AU3215795A (en) | Indole alkaloids useful as uv protective and anti-inflammatory agents | |
| NZ335252A (en) | Substituted 3-thia-1,2,3,4-tetrahydrocarbazole, 6,7,8,9-tetrahydropyrido[1,2-a]indole, 4,5-dihydro-thiopyrano[3,4-b]indole, pyrano[3,4-b]indole or beta-carbolinyl derivatives | |
| DE3376749T2 (de) | ||
| AU2747192A (en) | New phthalazines containing an ether or thioether group in the 1-position and a process for their preparation | |
| AU2093297A (en) | Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence | |
| HRP940004A2 (en) | New process for the preparation of sulfur derivatives of imidazole and new intermediates obtained | |
| CA2093510A1 (en) | Oxysulfonyl carbamates | |
| TW334428B (en) | Novel benzodiazepine derivatives | |
| TW262467B (de) | ||
| AU3350195A (en) | Bicyclic carboxamides as 5-HT-1A antagonists | |
| GB2264492B (en) | Benzodiazepine derivatives | |
| JPS6485950A (en) | Diethyl aromatic compound and production thereof | |
| GB2341552A (en) | Protective compositions |